MetLife Toekomstige groei

Future criteriumcontroles 1/6

MetLife zal naar verwachting groeien in winst en omzet met respectievelijk 13.2% en 4.4% per jaar. De winst per aandeel zal naar verwachting groeien met 16.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16% zijn.

Belangrijke informatie

13.2%

Groei van de winst

16.1%

Groei van de winst per aandeel

Insurance winstgroei	11.7%
Inkomstengroei	4.4%
Toekomstig rendement op eigen vermogen	16.0%
Dekking van analisten	Good
Laatst bijgewerkt	21 Nov 2024

Recente toekomstige groei-updates

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at MetLife, Inc. (NYSE:MET)

Jun 12

MetLife (NYSE:MET) Is Increasing Its Dividend To $0.545

Apr 27

MetLife: Healthy But Lacks Clear Advantages

Apr 18

MetLife, Inc.'s (NYSE:MET) P/E Is On The Mark

Apr 18

MetLife: A Safe Bet To Hold As Future Earnings Growth Expected, And Tailwind From Rate Environment

Feb 03

MetLife: Expected Net Investment Growth For Upcoming Earnings

Jan 26

MetLife, Inc.'s (NYSE:MET) P/S Is On The Mark

Jan 15

MetLife: Strong Capital Returns Make Shares Attractive (Ratings Upgrade)

Nov 15

MetLife: Disappointing Growth But Safe Dividend

Oct 26

MetLife: Neutral Rating Maintained, As Stock Remains Overvalued

Aug 18

MetLife: An Investment That Ensures Portfolios

Jul 12

MetLife institutional asset management arm to acquire Raven Capital

Feb 07

MetLife Q4 2022 Earnings Preview

Jan 31

MetLife declares $0.50 dividend

Jan 10

MetLife Is Trading Favorably On The Market

Dec 24

Looking Past Interest Rate Volatility Reveals MetLife Is A Hold

Oct 11

MetLife to acquire ESG-focused fixed income manager, Affirmative Investment

Aug 29

MetLife: Investors Should Look Past The Noisy Q2 2022 Results

Aug 12

MetLife declares $0.50 dividend

Jul 11

Winst- en omzetgroeiprognoses

NYSE:MET - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	78,350	6,333	N/A	9,099	6
12/31/2025	76,166	6,078	4,400	9,096	7
12/31/2024	73,010	4,603	N/A	8,708	7
9/30/2024	71,344	3,561	15,169	15,169	N/A
6/30/2024	68,770	2,708	14,475	14,475	N/A
3/31/2024	67,570	2,166	14,023	14,023	N/A
12/31/2023	66,901	1,380	13,721	13,721	N/A
9/30/2023	63,479	2,355	10,840	10,840	N/A
6/30/2023	69,896	3,031	11,675	11,675	N/A
3/31/2023	68,747	3,542	13,030	13,030	N/A
12/31/2022	68,764	5,099	13,044	13,044	N/A
9/30/2022	73,251	4,726	16,083	16,083	N/A
6/30/2022	67,873	5,149	15,279	15,279	N/A
3/31/2022	70,923	7,634	13,140	13,140	N/A
12/31/2021	68,688	6,654	12,347	12,347	N/A
9/30/2021	70,409	5,301	12,409	12,409	N/A
6/30/2021	69,519	4,413	12,696	12,696	N/A
3/31/2021	65,094	1,115	11,288	11,288	N/A
12/31/2020	67,842	5,191	11,639	11,639	N/A
9/30/2020	65,567	5,603	11,667	11,667	N/A
6/30/2020	68,230	7,122	12,020	12,020	N/A
3/31/2020	71,628	8,738	13,561	13,561	N/A
12/31/2019	69,620	5,721	13,786	13,786	N/A
9/30/2019	68,139	7,195	9,906	9,906	N/A
6/30/2019	65,750	5,923	9,293	9,293	N/A
3/31/2019	69,438	5,084	12,514	12,514	N/A
12/31/2018	67,941	4,982	11,738	11,738	N/A
9/30/2018	68,112	5,244	12,487	12,487	N/A
6/30/2018	67,980	5,235	N/A	13,688	N/A
3/31/2018	62,119	5,197	N/A	11,481	N/A
12/31/2017	62,308	4,893	N/A	12,283	N/A
9/30/2017	59,263	1,893	N/A	15,876	N/A
6/30/2017	58,908	2,044	N/A	14,069	N/A
3/31/2017	57,263	2,229	N/A	14,959	N/A
12/31/2016	60,732	3,481	N/A	14,774	N/A
9/30/2016	65,209	4,994	N/A	13,733	N/A
6/30/2016	67,255	5,169	N/A	13,445	N/A
3/31/2016	69,952	5,219	N/A	13,356	N/A
12/31/2015	61,257	3,891	N/A	14,052	N/A
9/30/2015	71,888	5,857	N/A	14,953	N/A
6/30/2015	72,677	6,724	N/A	16,343	N/A
3/31/2015	74,596	7,017	N/A	16,578	N/A
12/31/2014	73,265	6,190	N/A	16,376	N/A
9/30/2014	72,639	5,576	N/A	17,097	N/A
6/30/2014	70,514	4,452	N/A	15,738	N/A
3/31/2014	68,330	3,586	N/A	15,882	N/A
12/31/2013	69,396	3,244	N/A	16,131	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei MET ( 13.2% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van MET ( 13.2% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).

Hoge groeiwinsten: De winst van MET zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van MET ( 4.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van MET ( 4.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen MET zal naar verwachting over 3 jaar laag zijn ( 16 %).

MetLife Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 15%, revenue upgraded

Consensus EPS estimates fall by 13%

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Consensus EPS estimates fall by 12%

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of US$0.55 per share

MetLife Reportedly in Talks to Buy Richard Li's PineBridge Assets Outside of China

Second quarter dividend of US$0.55 announced

MetLife, Inc. Declares Fourth Quarter 2024 Common Stock Dividend, Payable on December 16, 2024

MetLife, Inc. to Report Q3, 2024 Results on Oct 30, 2024

MetLife, Inc.'s (NYSE:MET) P/E Still Appears To Be Reasonable

MetLife: One Of The Best Life Insurance Stocks

MetLife, Inc. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.55 per share

First quarter dividend of US$0.55 announced

MetLife Declares Common Stock Dividend for the Third Quarter of 2024, Payable on September 10, 2024

MetLife, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Metlife and GeoBlue Announce to Offer A Full Suite of Expatriate Benefit Products in A Best-In-Class Single Solution, Globaline™

Increases to CEO Compensation Might Be Put On Hold For Now at MetLife, Inc. (NYSE:MET)

MetLife, Inc. Appoints Shurawl Sibblies as Executive Vice President and Chief Human Resources Officer, Effective August 1, 2024

MetLife Launches My Leave Navigator to Support Employees Navigating Leave

New minor risk - Profit margin trend

New minor risk - Profit margin trend

MetLife, Inc. (NYSE:MET) announces an Equity Buyback for $3,000 million worth of its shares.

First quarter 2024 earnings: EPS and revenues miss analyst expectations

MetLife, Inc., Annual General Meeting, Jun 18, 2024

MetLife, Inc., Annual General Meeting, Jun 18, 2024

MetLife (NYSE:MET) Is Increasing Its Dividend To $0.545

Fourth quarter dividend increased to US$0.55

MetLife, Inc. Declares a Second Quarter 2024 Common Stock Dividend, Payable on June 11, 2024

MetLife: Healthy But Lacks Clear Advantages

MetLife, Inc.'s (NYSE:MET) P/E Is On The Mark

MetLife Expands Customer Experience Capability

MetLife, Inc. to Report Q1, 2024 Results on May 01, 2024

Key Executive recently sold US$2.0m worth of stock

Key Executive notifies of intention to sell stock

Metlife, Inc. Appoints Laura J. Hay as Director and to its Audit Committee and Finance and Risk Committee

New minor risk - Financial position

MetLife, Inc. Appoints Michelleta Razon as Head of Data Enablement

CEO, President & Director notifies of intention to sell stock

MetLife: A Safe Bet To Hold As Future Earnings Growth Expected, And Tailwind From Rate Environment

Full year 2023 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.52 per share at 2.9% yield

MetLife: Expected Net Investment Growth For Upcoming Earnings

MetLife, Inc.'s (NYSE:MET) P/S Is On The Mark

MetLife Declares First Quarter 2024 Common Stock Dividend, Payable on March 14, 2024

MetLife, Inc. to Report Q4, 2023 Results on Jan 31, 2024

MetLife: Strong Capital Returns Make Shares Attractive (Ratings Upgrade)

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of US$0.52 per share at 3.5% yield

MetLife: Disappointing Growth But Safe Dividend

MetLife, Inc. Declares Fourth Quarter 2023 Common Stock Dividend, Payable on December 14, 2023

MetLife, Inc. to Report Q3, 2023 Results on Nov 01, 2023

MetLife: Neutral Rating Maintained, As Stock Remains Overvalued

Metlife Investment Management Announces Final Close of Single Family Rental Fund At $390 Million

Consensus EPS estimates fall by 15%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$0.52 per share at 3.3% yield

MetLife: An Investment That Ensures Portfolios

MetLife, Inc. to Report Q2, 2023 Results on Aug 02, 2023

MetLife, Inc. Announces Leadership Changes

Consensus EPS estimates fall by 13%

MetLife, Inc. (NYSE:MET) announces an Equity Buyback for $3,000 million worth of its shares.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of US$0.52 per share at 3.3% yield

Investor sentiment deteriorates as stock falls 15%

Key Executive notifies of intention to sell stock

MetLife institutional asset management arm to acquire Raven Capital

Full year 2022 earnings: EPS and revenues miss analyst expectations

MetLife Q4 2022 Earnings Preview